Wireless Assessment of Respiratory and circulatory Distress (WARD) offers continuous 24/7 observation of high-risk patients with real-time alarms through innovative machine learning algorithms in a Clinical Support System (CSS).

What is WARD?

The Wireless Assessment of Respiratory and circulatory Distress (WARD) project creates an innovative clinical support system and was founded in 2016 as the first continuous and wireless monitoring system of vital signs with real-time AI-interpretation in Denmark. The WARD project integrates inputs from patient monitoring devices with intelligent algorithms to yield high-quality patient observation with real-time alarms triggered by patient vital sign deterioration.

Intended for use in several patient settings where the advantages and benefits of continuous monitoring may be fundamental. The WARD system has been used as monitoring in postoperative high-risk patients, in patients hospitalized with COPD, and lately in patients admitted with COVID-19 infection. 


WARD allows doctors and nursed to follow patients’ acute medical disease progression or postoperative course. The generation of real-time alarms will immediately alert relevant health care staff to allow initiation of treatment much earlier. Our well-designed, easy-to-use, and simple user interface offers health care professionals a valuable tool for overviewing current and historical vital signs. 


Daily routines of manual patient monitoring can be fundamentally changed to 24/7 observation of peripheral oxygen saturation, heart rate, respiration rate, blood pressure, etc. with alarms of important deviations. This may allow more efficient use of resources and the ability to give attention to the patients in special needs while at the same time keeping an eye on the remaining patients.


The WARD project will define, develop and implement the next generation monitoring system for high-risk patients, proving that it reduces complications and health care expenses. 

WARD Clinical Support System increase the quality of patient observation through continuous and wireless monitoring of patient vital signs. Combining innovative technology with evidence-based algorithms, we allow earlier and more frequent detection of patient deterioration through predictive AI-algorithms delivered in a user-friendly App.

Currently tested across Denmark's Regions

Randomized Clinical Trials is taking place in 2021-2022 to test the efficiency of continious wireless monitoring of patient deteroriation and WARD App in all of the Danish Regions.

First phase of RCT's will include 700 patients and will be followed by larger outcome trials.

Recent News

Here you can see and read the latest highlights about WARD.

‘Nyt om forskning’ focusing on the WARD project

A special edition of 'Nyt om forskningen' by the Danish Cancer Society https://www.cancer.dk/dyn/resources/File/file/3/9903/1663928156/nyt_om_forskning_aug_2022.pdf

Read More

WARD vinder CACHET Deployment Challenge Trophy

Selected from several nominations, the CACHET Deployment Trophy was awarded to the WARD project. https://www.cachet.dk/Events/Past-Events/CACHET-Spring-Seminar-2022

Read More

WARD CSS on Danish National Television

Read about the latest efforts of WARD CSS in the fight against the COVID-19 pandemic on Danish national television: https://nyheder.tv2.dk/samfund/2021-01-06-alarmer-skal-sikre-overvagning-af-coronasyge

Read More

WARD in the DTU Health Tech News

DTU Health Tech article about the application of WARD in the battle against COVID-19: https://www.healthtech.dtu.dk/english/news/Nyhed?id=%7BB659ECBB-9186-4648-9F66-7337DC625232%7D

Read More

Insight: New Technology Identifies COVID-19-Infected Patients

WARD CSS insight at the Ministry of Foreign Affairs of Denmark's investing website available here: https://investindk.com/insights/new-technology-identifies-covid-19-infected-patients

Read More

WARD in Dagens Medicin

A newly published article about the new aspects of WARD CSS in clinical setups is available at the following link (subscription required): https://dagensmedicin.dk/gennembrud-for-digitale-underskrifter-ved-kliniske-forskningsprojekter/

Read More

The Team

Eske Kvanner Aasvang
MD, DMSc, Professor
Anesthesiological Department Centre for Cancer and Organ Diseases - Rigshospitalet - University of Copenhagen - Denmark
Christian Sylvest Meyhoff
MD, PhD, Associate Professor
Department of Anaesthesia and Intensive Care - Bispebjerg and Frederiksberg Hospital - University of Copenhagen - Denmark
Helge Dissing Sørensen
MSc, PhD, Associate Professor
Department of Health Technology - Technical University of Denmark (DTU) - Denmark

Contact WARD247